{"name":"Nancy Lin, MD","slug":"nancy-lin-md","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMizgFBVV95cUxOWS1tcFctbXV5VXVwS1h4b3gzSDlIaGVMaWo5NHc1NmstZTFRWUd2RlI1UFBjWkJJYVQwTjZoMzdHUnhtNFlHc0JYZndWNGdZQ0JnbWVkdWVCa01ZNnR0R3FsMGhYcUFEWHBFWTQ2UDM2aU5xMWpRYTh3cUgxVlZ0dC0wd01kOFlzbWwyOUJGb2gxNGNSZVNVWFExZHZhSUJ4MXJYUVlSd1lLb1NISTBWcnJnZDVZdWM1RTB5ZFZHbkNLenZoSzBkV0Q2c3o4UQ?oc=5","date":"2026-02-02","type":"trial","source":"Healio","summary":"VIDEO: 2026 may bring more data, analyses on SERDs in metastatic breast cancer - Healio","headline":"VIDEO: 2026 may bring more data, analyses on SERDs in metastatic breast cancer","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMixgFBVV95cUxNTmVwSzNGSlh5TDlRU0dWWk9zRXNJVmNRbHBSMHZ0Ny0wX2lDdE1wMGQtTm1zdE5TSTk2dnJJUnAyLTVGZ1hNUXlPT1lFLTRpZTBSakxwVTB0bG1wTFdEZDV6VmM4aWJ2X1hlenF3dnNlN0NkT09vWGpjbnBoOEl4bktqUERrYzl4UFMtcVhNU1ZWQWdyM1BERkRWU1B0c1ZRanRDXy1MRk9CWU5iNi1fdEFRY2t1Smo0RmFaRHkweWZQc1hua3c?oc=5","date":"2026-01-15","type":"pipeline","source":"Healio","summary":"VIDEO: Access to latest treatments, supportive care key in breast cancer - Healio","headline":"VIDEO: Access to latest treatments, supportive care key in breast cancer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiywFBVV95cUxNVl9ZaFdESVlYWmtoRklNWHZFbTdCSDRkbUpoVHp5X2JTTXlOLW93WEc4Zlc1VGVWYTJaaTZlWnpVTWpNbHZwcjRBTXZDeDVEeVoyRlJ3ZzU5VHFxOEtPTFg3M2VNUnRjaVBTS2JmN2xOSGhCNlVpb0x6RTFjNklYRUxqc1RRcC1qWEgzdk40eWc3WDJnMjNkU3dETzlVQklZV29lQmVKVlJ2a3ZIWVNjOFBBOGg5Q0ZVbU5tTTBXOFFaV3BnRklKNERMNA?oc=5","date":"2026-01-15","type":"regulatory","source":"Healio","summary":"VIDEO: Accessibility, delays in diagnosis remain challenges in breast cancer - Healio","headline":"VIDEO: Accessibility, delays in diagnosis remain challenges in breast cancer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3wFBVV95cUxQRmpxcHJIOC1reG5iM19IVXFFQmYxX1R4WlRUSlc0aWplSEpjN2dtZmJsSHZyWnQxQ3F5WUo3d3N5U1hCcFA5dXJOdGN6VGk1UFNoWFlWSldwQmg2S0dKc3EzdGpyb0ZGSWg0QUxYSEVsU1VwRWJKZ0puZW03WGhCSUxtRGsyLV82bzlUTGx2dGlMZVViaU1TWTVvNm94dlRWZzVqRDYzWVNlYkhXRWFZUTQtcVBPNjZ4YWwxcERKS2dSLU9jQl8zYWJSTHA5Skw1ejVZaXk0bUxGTG9OSWtj?oc=5","date":"2026-01-15","type":"pipeline","source":"Healio","summary":"VIDEO: Further research needed on de-escalating, curative intent therapies in breast cancer - Healio","headline":"VIDEO: Further research needed on de-escalating, curative intent therapies in breast cancer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxNVHc1NnNiTHFYSm5WWVVzeGRmOGFma21fQU5Nd3I4Q2t3OUM5Tzc0Z1h5ZWliYmdrbDE1bW1PWTdhOTFsOGgwdlp0bUZHOGcyWkc5Tk0tdU9wMzMyWmMwVnU0bThBVEN5aTkyTlpMdno2cExtSnhQU0hrdmJ0T05ESV9UU1RocjdFWHBVT2l1dFR5NVRUNzdKalhGRF9fNHM0NUo0Nm5ab2FIZ3k1ZDdv?oc=5","date":"2026-01-05","type":"pipeline","source":"Healio","summary":"VIDEO: Explaining the HER2-low breast cancer diagnosis - Healio","headline":"VIDEO: Explaining the HER2-low breast cancer diagnosis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxQVXR3VHFQcGxZdDdCVEJtcGpWUEl1SnFOUXRXNWlGSWlBVnlUeVNHV0ZXbHhxV2FMVXIyd0ptajdwRDhlclh4WGxIcFBNRThTZGRzdEhZUTlsOHhTUzRCQWZjME1KODZvZUYxLTQxUHZFSjBEcENyemozRktNQzBadi01RUk3VC1weEZJUlY2Y0hfSEljNTZTZVBmejB1SDV4bHhpR25lWTJmOGtHNUhya2tVWk81Njh0alFmWUh2MVRqNmc?oc=5","date":"2026-01-05","type":"pipeline","source":"Healio","summary":"VIDEO: 'Dramatic improvements’ in HER2-positive breast cancer therapies - Healio","headline":"VIDEO: 'Dramatic improvements’ in HER2-positive breast cancer therapies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMie0FVX3lxTE9mYVBpQXdLYm9TNFNPSkNVQVFZM29NUV9EXzlSc3pGUXVvSTNCRHZQdy1wZGZTdi13b0F3Z1ROaXA3eTg4d3A2T0pKYnc0d21SZFp1UHRneFlLa1RoVHY2bTI1UjBaWXRQUFczYi1CdU5BWWN3YnJVZmxBOA?oc=5","date":"2025-01-30","type":"trial","source":"acsjournals.onlinelibrary.wiley.com","summary":"Outcomes and treatment patterns for stage I human epidermal growth factor receptor 2-positive breast cancer in the Surveillance, Epidemiology, and End Results database, 2010–2019 - acsjournals.onlinel","headline":"Outcomes and treatment patterns for stage I human epidermal growth factor receptor 2-positive breast cancer in the Surve","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxPbGE0NmZkblRSbVYxSFptMlB2dHpqVHJjb09xcmtXV25pdjJ4YkMtSW1aTGIwdHNrbDNOSUdNT01EVEI4NEhiUTRobHNGdE9EN1pFTDZOY3M5WEpNRE1kei02bklHWmw4dTd5Y1dqeks5NDJnX3dkQlEyR1lrLUlGMDZadUFUMzNNQUpwODJva3dXX1lpQ2xNRWdTY0dHVmhFVGdXWmpGb2VUeFctUjdoVGJuYmtUYXF1S0IyTTNsNA?oc=5","date":"2024-09-13","type":"pipeline","source":"Fierce Pharma","summary":"ESMO: AZ, Daiichi build case for Enhertu in breast cancer patients with brain metastases - Fierce Pharma","headline":"ESMO: AZ, Daiichi build case for Enhertu in breast cancer patients with brain metastases","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxQdlc4aUp4M1FiUmhRTzB4aTdkOTd0cWxUYzdULU1WaFR2dUl6OFd0Vi13bWRGb2EtcjVOTldTemNEbGdvV3RWS25SNDZmZ29qYkQxVFdQbnpDYnhTU2hFNDczdzRMWFh2UWs0RkJFZ1NiY2Q1TG96Mzl4aWZjdkF5encteWlTYzJ6b0dGdzNfQkxoNnJwRXpvaEFnUU9rWEpxU0s1ZmY1VlFrY0lyRVJPbFkxeWRhTko4?oc=5","date":"2024-09-13","type":"trial","source":"OncLive","summary":"DESTINY-Breast12 Data Support T-DXd Use in HER2+ Breast Cancer, Irrespective of Brain Mets - OncLive","headline":"DESTINY-Breast12 Data Support T-DXd Use in HER2+ Breast Cancer, Irrespective of Brain Mets","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMie0FVX3lxTFA4Zi1IRVVERHBqZzF0RzhHVUlDbVZGaEhfUUoyWURJRnRIZzJXMjlFZHFiRFFGUVU5a2xCMFJOY28tUzU1WFNtT25RR0dpal9DYmxIaW5tQnZRUUhtRGxmaVNLNEtPdURJWDM2OGNqYmlEb2Y4OXJ1Z296TQ?oc=5","date":"2022-09-07","type":"regulatory","source":"acsjournals.onlinelibrary.wiley.com","summary":"Efficacy of neoadjuvant chemotherapy in male breast cancer compared with female breast cancer - acsjournals.onlinelibrary.wiley.com","headline":"Efficacy of neoadjuvant chemotherapy in male breast cancer compared with female breast cancer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiYEFVX3lxTE94ZU5kc2NVMjRObEt2M2lhdnpuTndOT2R6ZWNuMWlYRS1DLVNfS19XckdzLVZVZVZ3TV9OVGZ5X1dvVThBN0xza3RNQld5UW41cU5hN2RCd1BXd3E2R0l4NQ?oc=5","date":"2019-12-11","type":"pipeline","source":"NEJM","summary":"Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer - NEJM","headline":"Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMie0FVX3lxTFBfYWUzU0tTbWtHYzFaNVNrU0lZdnYyYlBrSEY4RlExMExsUnE2TmJwb2Y2TTloSDFWRnY1MUIydjRBSjQ1eXNKNDUzOUlScmJ0NEFrYWxxdUotYUJiVzZNOW9raXJSY21PT3RfVTJ3NkpBT0h1VUZVYlBZbw?oc=5","date":"2013-08-26","type":"pipeline","source":"acsjournals.onlinelibrary.wiley.com","summary":"Long-term cardiac safety and outcomes of dose-dense doxorubicin and cyclophosphamide followed by paclitaxel and trastuzumab with and without lapatinib in patients with early breast cancer - acsjournal","headline":"Long-term cardiac safety and outcomes of dose-dense doxorubicin and cyclophosphamide followed by paclitaxel and trastuzu","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}